Imperial Chemical Industries PLC large chemical company United Kingdom expand specialty chemical drug business 1986 result chairman-elect Denys Henderson. "We expect shift company high value-added business continue broaden base" Henderson told reporter informal meeting here. ICI announce formation U.S. drug company ICI Pharma Stuart Pharmaceuticals unit double current pharmaceutical sale 1.1 billion dlrs 1990. Henderson "Our pharmaceutical get lose Glaxo's (Glaxo Holdings PLC) not." ICI's pharmaceutical division large drug maker behind Glaxo U.K. Last U.S. drug sale 40 pct worldwide drug sale 1.5 billion dlrs turn brought 27 pct total profits. He estimate 1990 ICI's pharmaceutical division account 30 pct total company profits. "The drug division brings high rate return" A.W. Clements finance director ICI meeting. Henderson U.S. drug concern basically act sale force double exposure drug doctors. ICI hire 145 salesperson October one. Henderson major product company's pipeline expect bring sale 200 mln dlrs annually Statil treatment diabetic complication Zoladex treatment advanced prostate cancer Carwin treatment mild moderate congestive heart failure. Henderson U.S. Food Drug Administration approval market Statil Zoladex joint licensing agreement Merck Co Inc MRK> expect 1989. ICI expect file permission market Carwin U.S. year. Henderson company's 1987 result top 1986 income 888 mln dlrs 5.45 dlrs ADR sale 15 billion dlrs decline specify much. Henderson 1987's result boost Glidden Paints ICI bought November 580 mln dlrs unit Hanson Industries Inc. Henderson ICI nine billion dlrs available acquisitions. Last company 40 acquisition large Glidden. He acquisition rule acquisition pharmaceutical concern "too expensive." Henderson role chairman effective April take Sir John Harvey-Jones retire big challenge ahead lay continue earnings momentum ICI establish past restructuring sell unprofitable businesses. Reuter 